Integra LifeSciences IART FX & Other Adjustments

FX & Other Adjustments at other companies

MedtronicMDT

——

CONMEDCNMD

——

Specialty Surgery-$1.07M—

Tissue Reconstruction-$841K—

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Market cap$1.38B+53.4%

Enterprise value$3.12B+21.1%

P/S0.8×+0.3×

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×